Genenta Science S.p.A.
NASDAQ:GNTA
3.94 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2023 Q4 | 2023 Q2 | 2022 Q4 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q4 | 2020 Q2 | 2019 Q4 | 2019 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 0.042 | 0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 0 | -0.042 | -0.021 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.04 | 2.553 | 3.885 | 3.698 | 1.641 | 0.191 | 3.199 | 2.616 | 2.072 | 1.851 | 1.851 |
| General & Administrative Expenses
| 2.478 | 2.38 | 1.439 | 3.191 | 2.514 | 1.454 | 0.842 | 0.497 | 0.405 | 0.461 | 0.461 |
| Selling & Marketing Expenses
| 0 | 0 | 2.829 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 2.478 | 2.38 | 2.831 | 3.191 | 2.514 | 1.454 | 0.842 | 0.497 | 0.405 | 0.461 | 0.461 |
| Other Expenses
| 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.018 | 0.018 |
| Operating Expenses
| 4.518 | 4.933 | 6.716 | 6.387 | 2.128 | 1.467 | 4.051 | 3.105 | 2.479 | 2.312 | 2.312 |
| Operating Income
| -4.518 | -4.933 | -6.737 | -6.89 | -4.154 | -1.646 | -4.041 | -3.113 | -2.477 | -2.312 | -2.312 |
| Operating Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 0.48 | 0.047 | 0.02 | 0.524 | 2.042 | 0.164 | -0.006 | 0.001 | -0.002 | 0.013 | 0.013 |
| Income Before Tax
| -4.039 | -4.886 | -6.696 | -6.365 | -2.112 | -1.481 | -4.048 | -3.113 | -2.479 | -2.299 | -2.299 |
| Income Before Tax Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 0 | 0 | 0.003 | 0 | 0 | 0 | 0 | 0 | 0 | 0.005 | 0.005 |
| Net Income
| -4.039 | -4.886 | -6.696 | -6.365 | -2.112 | -1.481 | -4.048 | -3.113 | -2.479 | -2.304 | -2.304 |
| Net Income Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.22 | -0.27 | -0.37 | -0.34 | -0.116 | -0.096 | -0.28 | -0.22 | -0.172 | -0.12 | -0.12 |
| EPS Diluted
| -0.22 | -0.27 | -0.37 | -0.34 | -0.116 | -0.096 | -0.28 | -0.22 | -0.172 | -0.12 | -0.12 |
| EBITDA
| -4.496 | -4.911 | -3.39 | -6.887 | -4.151 | -1.643 | -4.039 | -3.112 | -2.476 | 0 | 0 |
| EBITDA Ratio
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |